ArticleInvestigative ophthalmology & visual science2025
Assessing the Independent and Combined Effects of Hyperosmolarity and Inflammatory Stress on Human Corneal Epithelial Cells.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Association of IL-8 and IL-18 Expression With Histone-Associated NETosis in Aqueous-Deficient and Evaporative Dry Eye Disease.Investigative ophthalmology & visual science · 2026Article
- Mechanistic Insights Into UC-MSC Therapy in a BAC-Induced Dry Eye Model: TSG-6-Dependent Inhibition of the Th17/CCL20-CCR6 Chemotactic Axis.Investigative ophthalmology & visual science · 2026Article
- Wogonoside alleviates hyperosmotic stress-induced inflammation and apoptosis in human corneal epithelial cells via PI3K/AKT signaling.Frontiers in medicine · 2026Article
- Ocular social jetlag: a driver of immune-metabolic dysfunction in dry eye disease.Frontiers in immunology · 2026Review
- Correlation between tear cytokine profiles and corneal injury degree in patients with dry eye syndrome.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Inflammation and hyperosmolarity drive dry eye disease (DED) by inducing oxidative stress, apoptosis, and immune activation, disrupting tear film homeostasis and epithelial integrity. This study aimed to evaluate the independent and combined effects of hyperosmolarity and inflammatory stress on human corneal epithelial (HCE) cells. Methods: HCE cells were exposed to hyperosmolar conditions using sodium chloride, lipopolysaccharide, or a combination of both for 12, 24, and 48 hours. The effects on cell adhesion, cell proliferation, cytokine secretion, and gene expression were analyzed. Expression of genes and inflammatory cytokines was evaluated for stress response pathways and antioxidant marker regulation. Results: LPS exposure alone significantly increased inflammatory cytokine secretion at 24 hours (e.g. IL-8 = 2481.4 ± 32.5, P < 0.001; IL-17 = 1095 ± 32, P < 0.01) but did not affect adhesion. The combination of LPS and hyperosmolar stress exacerbated cellular damage, with increased levels of IL-6, TNF-α, IL-1β, and TLR2 and 4. Gene expression analysis revealed upregulation of stress response genes (HMOX-1 = 13 ± 1.5, P < 0.001; COX2 = 2.2 ± 0.1, P < 0.001; and TonEBP = 4.7 ± 1.7, P < 0.001) and downregulation of antioxidant markers (SOD1 = 0.5 ± 0.0, P < 0.001). Cytokine and oxidative stress marker secretion (IL-2, IL-8, IL-12, IL-17, IL-23, HMOX-1, COX2, and SOD1) peaked at 48 hours under hyperosmolar and combined stress conditions. Conclusions: This study demonstrates for the first time the combined effect of hyperosmolarity and inflammation that disrupts corneal epithelial homeostasis in vitro, leading to increased oxidative stress by expressing HMOX1, COX2, TonEBP, HIF1, and inflammatory cytokine production. These findings provide further insights into the pathophysiology of DED and support the development of an in vitro model that mitigates hyperosmolar and inflammatory stress-induced epithelial defects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.